1xbetÍøÒ³°æ

1xbetÍøÒ³°æ - Ëѹ·Ö¸ÄÏ

1xbetÍøÒ³°æ: Ñо¿³É¹û

1xbetÍøÒ³°æ:1xbetÍøÒ³°æ³É¹û¡°ÐÂÐ͹Ú×´²¡¶¾ÌÓÒÝËÞÖ÷ÌìÈ»ÃâÒߺͿ¹²¡¶¾Ò©ÎïµÄ»úÖÆ¡±ÈëÑ¡2021Äê¶ÈÖйúÉúÃü¿ÆÑ§Ê®´ó½øÕ¹

2022-01-11

1ÔÂ10ÈÕ£¬Öйú¿ÆÐ­ÉúÃü¿ÆÑ§Ñ§»áÁªºÏÌ幫²¼2021Äê¶È¡°ÖйúÉúÃü¿ÆÑ§Ê®´ó½øÕ¹¡±£¬Ç廪´óѧÈÄ×ÓºÍԺʿÍŶÓÏîÄ¿³É¹û¡°ÐÂÐ͹Ú×´²¡¶¾ÌÓÒÝËÞÖ÷ÌìÈ»ÃâÒߺͿ¹²¡¶¾Ò©ÎïµÄ»úÖÆÑо¿¡±ÈëÑ¡¡£

Öйú¿ÆÐ­ÉúÃü¿ÆÑ§Ñ§»áÁªºÏÌå×Ô2015ÄêÆð¿ªÕ¹Äê¶È¡°ÖйúÉúÃü¿ÆÑ§Ê®´ó½øÕ¹¡±ÆÀÑ¡¹¤×÷£¬ÒÑÁ¬Ðø¿ªÕ¹7Äּ꣬ÔÚÍÆ¶¯ÉúÃü¿ÆÑ§Ñо¿ºÍ¼¼Êõ´´Ð£¬³ä·ÖչʾºÍÐû´«ÎÒ¹úÉúÃü¿ÆÑ§ÁìÓòµÄÖØ´ó¿Æ¼¼³É¹û¡£2021Äê¶ÈÈëÑ¡µÄ¡°ÖйúÉúÃü¿ÆÑ§Ê®´ó½øÕ¹¡±°üÀ¨8¸ö֪ʶ´´ÐÂÀàºÍ2¸ö¼¼Êõ´´ÐÂÀàÏîÄ¿³É¹û£¬¾ßÓÐÔ­´´ÐÔÍ»³ö¡¢Éç»áÒâÒåÖØ´óµÄÌØµã¡£

ÐÂÐ͹Ú×´²¡¶¾ÌÓÒÝËÞÖ÷ÌìÈ»ÃâÒߺͿ¹²¡¶¾Ò©ÎïµÄ»úÖÆ

йڲ¡¶¾·ÎÑ×ÒßÇéÒѳÖÐøÁ½Ä꣬²»¶Ï³öÏÖµÄÍ»±äÖê¶Ô·¢Õ¹¹ãÆ×Ò©ÎïÌá³ö¼±ÆÈÐèÇó¡£Óɲ¡¶¾¸´ÖÆÃ¸×é³É¡°×ªÂ¼¸´ÖƸ´ºÏÌ塱£¬¸ºÔ𲡶¾×ªÂ¼¸´ÖƵÄÈ«¹ý³Ì£¬ÔÚ¸÷Í»±äÖêÖи߶ȱ£ÊØ£¬ÊÇ¿ª·¢¹ãÆ×Ò©ÎïµÄºËÐİеã¡£

Ç廪´óѧÈÄ×ÓºÍԺʿ¡¢Â¦ÖÇÓ½ÌÊÚ¿ÎÌâ×飬ÔÚ¹ú¼ÊÉÏÊ״η¢ÏÖºÍÖØ¹¹ÁËйڲ¡¶¾×ªÂ¼¸´ÖÆ»úÆ÷µÄÍêÕû×é³ÉÐÎʽ¡£ÒÔ´ËΪ»ù´¡£¬Ê×´ÎÃ÷È·Á˲¡¶¾mRNA¡°¼Óñ¡±³ÉÊìµÄ¹Ø¼üø·Ö×Ó£¬»Ø´ðÁ˹Ú×´²¡¶¾Ñо¿Öнü30ÄêÀ´Ðü¶øÎ´¾öµÄÎÊÌ⣬²¢ÇҸ÷Ö×ÓÔÚ¸÷Í»±äÖêÖи߶ȱ£ÊØ£¬ÔÚÈËÌåÖÐûÓÐͬԴÎΪ·¢Õ¹ÐÂÐÍ¡¢°²È«µÄ¹ãÆ×¿¹²¡¶¾Ò©ÎïÌṩÁËȫае㡣ͬʱ£¬ËûÃÇ»¹Ê״η¢ÏÖ²¡¶¾ÒÔ¡°·´Ê½»ØËÝ¡±µÄ·½Ê½¶Ô´íÅä¼î»ùºÍ¿¹²¡¶¾Ò©Îï½øÐС°ÌÞ³ý¡±£¬²ûÃ÷ÁËÈðµÂÎ÷ΤµÈÒ©ÎïЧ¹û²»Á¼µÄ·Ö×Ó»úÖÆ£¬ÎªÓÅ»¯Õë¶Ô¾ÛºÏøµÄ¿¹²¡¶¾Ò©ÎïÌṩÁ˹ؼü¿ÆÑ§ÒÀ¾Ý¡£

ÒÔÉÏÑо¿³É¹û·Ö±ð·¢±íÓÚ¡¶Ï¸°û¡·ÔÓÖ¾£¨Cell, 184(1):184-193; Cell, 184(13):3474-3485£©¡£

йڲ¡¶¾×ªÂ¼¸´ÖƸ´ºÏÌåµÄmRNA¼Óñ״̬Óë¸´ÖÆÐ£Õý״̬ͼ

ÐÂÎÅÀ´Ô´£ºÖйú¿ÆÐ­ÉúÃü¿ÆÑ§Ñ§»áÁªºÏÌå

http://www.culss.org.cn/index.php?m=content&c=index&a=show&catid=33&id=294

ɨÃèÉÏ·½¶þάÂëÖ±´ïÐÂÎÅÔ­ÎÄÁ´½Ó

¸½´ËÏîÑо¿³É¹ûµÄ½éÉÜÈçÏ£º

1.  ÈÄ×ÓºÍԺʿºÍ¦ÖÇÓÂÍŶӽÒʾйڲ¡¶¾RNA¡°Ã±½á¹¹ºÏ³É¡±·Ö×Ó»úÖÆ

йڲ¡¶¾µÄmRNAÐèÒªÒ»¸ö¶ÀÌØµÄ¡°Ã±½á¹¹¡±£¨cap£©£¬°ïÖúÍê³É²¡¶¾µ°°×ÖÊ·­Òë¡¢ÌÓÒÝËÞÖ÷ÏÈÌìÃâÒßµÈÉúÀí¹ý³Ì¡£Ã±½á¹¹¼Ó¹¤·ÖΪËIJ½£¬¼´£¨1£©ÓÉpppA-RNAÉú³ÉppA-RNA[cap(-2)]¡¢£¨2£©ºÏ³ÉGpppA-RNA [cap(-1)]¡¢£¨3£©ºÏ³É7MeGpppA-RNA[cap(0)]ºÍ£¨4£©ºÏ³É7MeGpppA2¡¯OMe-RNA[cap(1)]¡£2021Äê1ÔÂ7ÈÕ£¬Â¦ÖÇÓÂÑо¿Ô±¼°ÈÄ×ÓºÍԺʿÍŶÓÔÚ¡¶Ï¸°û¡·ÔÓÖ¾£¨Cell£©·¢±íÌâΪ ¡°Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis¡±(йڲ¡¶¾Ã±ºÏ³ÉÖмä̬ת¼¸´ºÏÌåµÄÀä¶³µç¾µ½á¹¹)µÄÑо¿ÎÄÕ£¬Õ¹Ê¾Ð¹ڲ¡¶¾mRNA¼ÓñµÚ¶þ²½ÏòµÚÈý²½¹ý¶É¹ý³ÌµÄ¹Ø¼ü¸´ºÏÎïcap(-1)¡¯-RTC£¬½âÎöÆä2.8°£µÄÀä¶³µç¾µ½á¹¹¡£¸Ã½á¹¹ÓÉnsp7-nsp82-nsp12-nsp132-RNA£¨E-RTC£©ºÍRNAµ¥Á´½áºÏµ°°×nsp9×é×°¶ø³É¡£nsp9ͨ¹ýÆäN¶Ë°±»ùËáÓë¾ÛºÏønsp12ÉϵĺËÜÕ×ªÒÆÃ¸£¨NiRAN£©½á¹¹Óò½áºÏ£¬Òýµ¼Ã±ºÏ³É¹ý³ÌÓɵڶþ²½ÏòµÚÈý²½µÄ¹ý¶É¡£Ëæºó£¬½øÒ»²½Ö¤Êµ¾ÛºÏønsp12µÄNiRAN½á¹¹Óò¸ºÔð´ß»¯Ã±½á¹¹ºÏ³ÉµÄµÚ¶þ²½Ã¸Ñ§·´Ó¦£¬»Ø´ðÁ˹Ú×´²¡¶¾Ñо¿Öнü20ÄêÀ´Ðü¶øÎ´¾öµÄÎÊÌ⣬Ê״γ¹µ×Ã÷È·ÁËmRNAºÏ³É¹ý³ÌÖÐÈ«²¿µÄ¹Ø¼üø·Ö×Ó£¬Îª¿¹²¡¶¾Ò©ÎïÑз¢ÌṩÁËеİеã¡£ÕâÊÇÓÉÀ´×ÔÇ廪´óѧ¡¢ÉϺ£¿Æ¼¼´óѧºÍÎ人´óѧµÄÑо¿ÈËÔ±¹²Í¬Õ¹Ê¾µÄSARS-CoV-2¡°Ã±½á¹¹ºÏ³É¡±µÄ¸´ºÏÎï½á¹¹¿ìÕÕ¡£ÆäÖУ¬Ç廪´óѧ¦ÖÇÓÂÑо¿Ô±¡¢ÈÄ×ÓºÍԺʿΪͨѶ×÷Õߣ¬»ù´¡Ò½Ñ§ÏµãÆÀûÃ÷ÀÏʦΪµÚÒ»×÷Õß¡£

SARS-CoV-2 mRNA¡°Ã±½á¹¹ºÏ³É¡±¸´ºÏÎï½á¹¹

ɨÃèÉÏ·½¶þάÂëÖ±´ïÔ­ÎÄ

2.  ÈÄ×ÓºÍԺʿºÍ¦ÖÇÓÂÍŶӷ¢±íºÏ×÷Ñо¿³É¹û²ûÃ÷йڲ¡¶¾mRNAºÏ³É¡¢»ùÒò×鏴֯½ÃÕýºÍÌÓÒݺËÜÕÀ࿹²¡¶¾Ò©ÎïµÄ·Ö×Ó»úÖÆ

2021Äê5ÔÂ24ÈÕ£¬Ç廪´óѧ¦ÖÇÓÂÑо¿Ô±¼°ÈÄ×ÓºÍԺʿÍŶÓÓëÉϺ£¿Æ¼¼´óѧ¸ßÑÒ¸±Ñо¿Ô±ºÏ×÷ÔÚ¡¶Ï¸°û¡·ÔÓÖ¾(Cell)·¢±íÑо¿ÂÛÎÄ¡°Coupling of N7-methyltransferase and 3¡ä-5¡äexoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading¡±(йڲ¡¶¾N7¼×»ù×ªÒÆÃ¸ºÍ3¡ä-5¡äºËËáÍâÇÐøÓë¾ÛºÏøµÄ¸´ºÏÌå½ÒʾRNA¼ÓñºÍ´íÅä½ÃÕýµÄ·Ö×Ó»úÖÆ)µÄÑо¿ÂÛÎÄ£¬½âÎöйڲ¡¶¾³¬·Ö×Óµ°°×ÖÊ»úÆ÷¡°×ªÂ¼¸´ÖƸ´ºÏÌ塱¹Ø¼ü״̬µÄÈýά½á¹¹£¬½ÒʾÁ˲¡¶¾mRNA¼Óñ£¨capping£©¡¢»ùÒò×鏴֯½ÃÕý£¨proofreading£©¡¢ÌÓÒݺËÜÕÀ࿹²¡¶¾Ò©ÎïµÄ·Ö×Ó»úÖÆ¡£mRNAµÄ¼ÓñºÍ¸´ÖƽÃÕý£¬ÔÚйڲ¡¶¾µÄ¸´ÖƺÍת¼¹ý³ÌÖÐÆð×ÅÖÁ¹ØÖØÒªµÄ×÷Ó᣼òµ¥À´Ëµ£¬¼ÓñָµÄÊÇÔÚ²¡¶¾mRNAǰ¶Ë¼ÓÉÏÒ»¸öñ½á¹¹£¬¿ÉÒÔÔö¼ÓmRNAµÄÎȶ¨ÐÔ£¬±£Ö¤ºóÐøµÄµ°°×·­Ò룻¸´ÖƽÃÕýÔòÊÇÀûÓÃת¼¸´ÖƸ´ºÏÌåÖеĵ°°×£¬¿ìËÙ´¦Àí¸´ÖÆ¹ý³ÌÖгöÏÖ´íÎóÅä¶ÔµÄ¼î»ù£¬ËæÊ±½øÐÐÐÞÕý¡£ÕâÁ½¸ö»úÖÆ£¬±£Ö¤ÁËйڲ¡¶¾¿ÉÒÔÏà¶Ô׼ȷµØÉú²ú³öËùÐèµÄµ°°×ÖÊ£¬Ò²ÊDz¡¶¾¿ÉÒÔÌÓÍѺËÜÕÀ࿹²¡¶¾Ò©ÎÈçÈðµÂÎ÷Τ£©×÷ÓõĹؼü¡£

ÖÓÄÏɽԺʿÆÀÂÛ˵£¬¶ÔÕâÒ»»úÖÆÕ¹¿ªµÄÉîÈëÑо¿£¬½«Îª½ñºó·¢Õ¹¹ãÆ×¡¢¸ßЧµÄ¿¹¹Ú×´²¡¶¾Ò©ÎïÌṩ¹Ø¼üµÄ¿ÆÑ§ÐÅÏ¢¡£

ÕâÊǸÃÍŶÓÔÚйڲ¡¶¾×ªÂ¼¸´ÖƸ´ºÏÌåÑо¿ÖУ¬¼ÌÔÚ¡¶¿ÆÑ§¡·(Science)¡¢¡¶Ï¸°û¡·£¨Cell£©µÈÆÚ¿¯ÉÏÁ¬Ðø·¢±í4Ïî³É¹ûºóµÄÓÖÒ»ÖØÒª¹¤×÷¡£¸Ã³É¹ûÒ²½«¶ÔδÀ´½øÒ»²½ÓÅ»¯ºÍ·¢Õ¹ÐÂÐͺËÜÕÀ࿹²¡¶¾Ò©ÎïÌṩ¹Ø¼üµÄ½á¹¹»ù´¡¡£Ç廪´óѧ¦ÖÇÓÂÑо¿Ô±¡¢ÈÄ×ÓºÍԺʿºÍÉϺ£¿Æ¼¼´óѧµÄ¸ßÑÒ¸±Ñо¿Ô±Îª¹²Í¬Í¨Ñ¶×÷Õߣ¬1xbetÍøÒ³°æÖúÀíÑо¿Ô±ãÆÀûÃ÷²©Ê¿¡¢²©Ê¿ºóÑîÔÆÏ裬ÒÔ¼°²©Ê¿ÉúÀîÃ÷Óî¡¢ÕÅÓ¯¡¢Ö£ÀñÌΡ¢¸ð»ù¡¢»ÆÓêᯡ¢ÁõÕðÓîΪ¹²Í¬µÚÒ»×÷Õß¡£

йڲ¡¶¾¸´ÖƽÃÕýµÄ·´Ê½»ØËÝ£¨in trans backtracking£©»úÖÆ

»ùÓÚCap£¨0£©-RTCµÄÈýά»ú¹¹£¬²ûÃ÷ÁËйڲ¡¶¾¼ÓñºÍ¸´ÖƽÃÕýµÄ·Ö×Ó»úÖÆ

ɨÃèÉÏ·½¶þάÂëÖ±´ïÔ­ÎÄ

ÉÏÒ»Ìõ£ºÈÄ×ÓºÍԺʿÍŶӺÍÕÅÁÖçù½ÌÊÚ/ÍõÐÂȪ½ÌÊÚÍŶӳɹûÈëÑ¡2020ÄêÖйú°Ùƪ×î¾ßÓ°Ïì¹ú¼ÊѧÊõÂÛÎÄ

ÄúÏÖÔÚµÄλÖ㺠Ê×Ò³ > ¿ÆÑ§Ñо¿ > Ñо¿³É¹û > ÕýÎÄ
1xbetÍøÒ³°æ - Ëѹ·Ö¸ÄÏ